Evidence map›Paper›PMID 21813616›Full record

ArticleJournal of virology2011

HLA-DR+ CD38+ CD4+ T lymphocytes have elevated CCR5 expression and produce the majority of R5-tropic HIV-1 RNA in vivo.

Amie L Meditz, Michelle K Haas, Joy M Folkvord, Kelsey Melander, Russ Young, Martin McCarter, Samantha Mawhinney, Thomas B Campbell, Yolanda Lie, Eoin Coakley and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 2 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 2 syntheses or guidelines pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. HIV post-treatment controllers have distinct immunological and virological features.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  17. Genital Immune Cell Activation and Tenofovir Gel Efficacy: A Case-Control Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  18. Article
  19. Review
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Amie L MeditzDepartment of Medicine, University of Colorado Denver, Aurora, CO 80045, USA.
Michelle K Haas
Joy M Folkvord
Kelsey Melander
Russ Young
Martin McCarter
Samantha Mawhinney
Thomas B Campbell
Yolanda Lie
Eoin Coakley
David N Levy
Elizabeth Connick
University of Colorado Denver · USNew York University · US

Funding

U of Colorado Center for AIDS ResearchP30AI054907 · NIAID · UNIVERSITY OF COLORADO DENVER · PI WILSON, CARA C. · 2003 to 2008
$9.6M
UNIVERSITY OF COLORADO HIV RESEARCH TRAINING PROGRAMT32AI007447 · NIAID · UNIVERSITY OF COLORADO DENVER · PI CAMPBELL, THOMAS B. · 1992 to 2016
$2.8M
Influence of Sex Steroids on HIV-1 Chemokine Coreceptor Expression in WomenK08AI080285 · NIAID · UNIVERSITY OF COLORADO DENVER · PI MEDITZ, AMIE L · 2009 to 2013
$661k
Sex Differences in Plasma HIV-1 RNA ConcentrationsR21HD051450 · NICHD · UNIVERSITY OF COLORADO DENVER · PI CONNICK, ELIZABETH · 2006 to 2010
$548k
NIAID NIH HHS K08 AI080285NIAID NIH HHS P30 AI054907NIAID NIH HHS T32 AI007447NICHD NIH HHS R21 HD051450NICHD NIH HHS R21HD051450
6 · The paper itself

Abstract

Percentages of activated T cells correlate with HIV-1 disease progression, but the underlying mechanisms are not fully understood. We hypothesized that HLA-DR(+) CD38(+) (DR(+) 38(+)) CD4(+) T cells produce the majority of HIV-1 due to elevated expression of CCR5 and CXCR4. In phytohemagglutinin (PHA)-stimulated CD8-depleted peripheral blood mononuclear cells (PBMC) infected with HIV-1 green fluorescent protein (GFP) reporter viruses, DR(-) 38(+) T cells constituted the majority of CCR5 (R5)-tropic (median, 62%) and CXCR4 (X4)-tropic HIV-1-producing cells (median, 61%), although cell surface CCR5 and CXCR4 were not elevated in this subset of cells. In lymph nodes from untreated individuals infected with R5-tropic HIV-1, percentages of CCR5(+) cells were elevated in DR(+) 38(+) CD4(+) T cells (median, 36.4%) compared to other CD4(+) T-cell subsets (median values of 5.7% for DR(-) 38(-) cells, 19.4% for DR(+) 38(-) cells, and 7.6% for DR(-) 38(+) cells; n = 18; P < 0.001). In sorted CD8(-) lymph node T cells, median HIV-1 RNA copies/10(5) cells was higher for DR(+) 38(+) cells (1.8 × 10(6)) than for DR(-) 38(-) (0.007 × 10(6)), DR(-) 38(+) (0.064 × 10(6)), and DR(+) 38(-) (0.18 × 10(6)) subsets (n = 8; P < 0.001 for all). After adjusting for percentages of subsets, a median of 87% of viral RNA was harbored by DR(+) 38(+) cells. Percentages of CCR5(+) CD4(+) T cells and concentrations of CCR5 molecules among subsets predicted HIV-1 RNA levels among CD8(-) DR/38 subsets (P < 0.001 for both). Median HIV-1 DNA copies/10(5) cells was higher in DR(+) 38(+) cells (5,360) than in the DR(-) 38(-) (906), DR(-) 38(+) (814), and DR(+) 38(-) (1,984) subsets (n = 7; P ≤ 0.031). Thus, DR(+) 38(+) CD4(+) T cells in lymph nodes have elevated CCR5 expression, are highly susceptible to infection with R5-tropic virus, and produce the majority of R5-tropic HIV-1. PBMC assays failed to recapitulate in vivo findings, suggesting limited utility. Strategies to reduce numbers of DR(+) 38(+) CD4(+) T cells may substantially inhibit HIV-1 replication.

Indexed as

ADP-ribosyl Cyclase 1AdultCD4 AntigensFemaleHIV-1HLA-DR AntigensHumansLymph NodesMaleMembrane GlycoproteinsMiddle AgedReceptors, CCR5Receptors, HIVRNA, ViralT-Lymphocyte SubsetsADP-ribosyl Cyclase 1CD38 protein, humanCD4 AntigensHLA-DR AntigensMembrane GlycoproteinsReceptors, CCR5Receptors, HIVRNA, Viral

Identifiers

PMID21813616
PMCPMC3196402
OpenAlexW2133326570

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.